Home Carboxes 174606-16-7
174606-16-7,MFCD03840048
Catalog No.:AA001ZPS

174606-16-7 | 1-[(tert-Butyl)oxycarbonyl]-3-(4-chlorobenzyl)piperidine-3-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
≥ 98% (HPLC)
in stock  
$112.00   $79.00
- +
250mg
≥ 98% (HPLC)
in stock  
$190.00   $133.00
- +
1g
≥ 98% (HPLC)
in stock  
$428.00   $299.00
- +
5g
≥ 98% (HPLC)
in stock  
$1,512.00   $1,058.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001ZPS
Chemical Name:
1-[(tert-Butyl)oxycarbonyl]-3-(4-chlorobenzyl)piperidine-3-carboxylic acid
CAS Number:
174606-16-7
Molecular Formula:
C18H23ClNO4-
Molecular Weight:
352.8325
MDL Number:
MFCD03840048
SMILES:
Clc1ccc(cc1)CC1(CCCN(C1)C(=O)OC(C)(C)C)C(=O)[O-]
Properties
Computed Properties
 
Complexity:
468  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
XLogP3:
3.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:MERCK&COINC-US5475109,1995,A

174606-16-7   
(3R,7S,10S,13R)-3-((E)-but-2-en-1-yl)-6-(4-chloro-2-(4-(2-((dimethylamino)methyl)-1-methyl-1H-imidazol-5-yl)phenoxy)benzyl)-13-(4-chlorobenzyl)-10-(hydroxymethyl)-7-methyl-1,6,9,12-tetraazabicyclo11.3.1heptadecane-2,5,8,11-tetraone 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

174606-16-7   
(R,E)-tert-butyl3-((R)-3-((S)-3-((S)-2-((4-chloro-2-(4-(2-((dimethylamino)methyl)-1-methyl-1H-imidazol-5-yl)phenoxy)benzyl)amino)propanoyl)-2,2-dimethyloxazolidine-4-carboxamido)-3-(4-chlorobenzyl)piperidine-1-carbonyl)hept-5-enoate 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

174606-16-7   
(R,E)-3-((R)-3-((S)-2-((S)-2-((4-chloro-2-(4-(2-((dimethylamino)methy)-1-methyl-1H-imidazol-5-yl)phenoxy)benzyl)amino)propanamido)-3-hydroxypropanamido)-3-(4-chlorobenzyl)piperidine-1-carbonyl)hept-5-enoicacid 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

174606-16-7   
(3R,7S,10S,13R)-7-(2-aminoethyl)-3-benzyl-6-(4-chloro-2-(4-(2-((dimethylamino)methyl)-1-methyl-1H-imidazol-5-yl)phenoxy)benzyl)-13-(4-chlorobenzyl)-10-(hydroxymethyl)-1,6,9,12-tetraazabicyclo11.3.1heptadecane-2,5,8,11-tetraone 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2020/164024,2020,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2021/156792,2021,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:174606-16-7 Molecular Formula|174606-16-7 MDL|174606-16-7 SMILES|174606-16-7 1-[(tert-Butyl)oxycarbonyl]-3-(4-chlorobenzyl)piperidine-3-carboxylic acid